Generic vs Branded Chemotherapy — Are They Actually the Same Drug?

The active molecule is chemically identical and present at the same strength, and CDSCO requires bioequivalence testing before a generic is approved, meaning it must be absorbed by the body in a comparable way to the original. No bioequivalence study can replicate every individual clinical outcome — bodies differ, and factors beyond the molecule can affect how a person responds. Your oncologist is the right person to explain why a specific drug was chosen for you and what to expect from it.

Most cancer centres in India use generics routinely, because the active molecule is the same and the cost difference is significant — for both the centre and for you. Using a generic is not a lower standard of care. If you want to understand why a specific version was chosen, asking your team directly is entirely reasonable and a question they are used to answering.

You can ask. Your team will explain what is available at your centre and whether there is a clinical or practical reason for the version you are being given. In most cases there is no clinical difference between approved versions of the same molecule. Do not switch versions yourself or obtain chemotherapy from outside your centre without telling your team — chemotherapy must be handled and administered under proper conditions.

Switching between versions of the same molecule does happen, and in most cases it does not affect your treatment. The important thing is that your team knows, so they can note it in your record and watch for any change in how you respond or tolerate the drug. If you notice anything different after a switch — in how you feel or in your side effects — mention it at your next visit rather than assuming it is unrelated.

Yes — India is one of the world's largest producers of generic medicines and supplies drugs to health systems in Europe, the United States, and through WHO procurement programmes. CDSCO approval, GMP certification, and an international supply track record are the relevant measures — not the country of manufacture alone. That said, quality can vary between manufacturers, which is why how a centre sources its drugs matters. Reputable treatment centres source from approved, certified manufacturers.

Tell your oncologist or their team before you miss a dose or try to find the drug from another source. Most centres have a social worker or patient counsellor who can help you explore options — government schemes, hospital assistance funds, or manufacturer patient access programmes. Missing a dose or using a drug obtained outside the centre without your team's knowledge is the outcome your team most needs to help you avoid.